Adjuvant immunotherapy. Treatment of high risk patients with malignant melanoma.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000628:therapy*; D009367:Neoplasm Staging; D012878:Skin Neoplasms / Q000628:therapy*
D000276:Adjuvants, Immunologic